Skip to main content
>
Science News

Study pinpoints rare genetic change that may boost risk of HPV-related illness

human papilloma virus

HPV, a wart-inducing virus.

Generally speaking, the immune system does a good job safeguarding us from various types of the human papilloma virus (HPV), best known as the perpetrator of skin and genital warts. Although most people do get infected at some point in their lives, the virus is usually kept in check so that no symptoms develop.

An exception is rare cases of children born to HPV-infected women who get the virus from their mother and develop persistent warts in the throat. Until now, it hasn’t been known why certain kids develop these symptoms.

The answer may lurk in their genes, according to a new study of two boys with warts in the throat. A team of Rockefeller scientists identified a genetic variant that may have made these children’s immune systems overreact to the virus.

“We’ve cracked the enigma of why the boys developed these warts,” says lead investigator Jean-Laurent Casanova, head of the St. Giles Laboratory of Human Genetics of Infectious Diseases.

The findings add to a growing body of evidence that is changing how researchers think about infectious disease. The field was long focused exclusively on pathogens, but Casanova’s lab and others have found that many of these conditions are not caused soley by an infection. “They’re also genetic disorders,” he says.

Cracking the enigma

Recurrent respiratory papillomatosis affects roughly one in 50,000 children and can lead to difficulty breathing and swallowing, among other problems. The warts can be temporarily removed with laser surgery, but they almost always grow back.

The researchers sequenced DNA from two brothers with the condition and from both of their healthy parents to look for a connection between the boys’ genes and their warts. They found five genes for which both boys had inherited the same rare mutations. These mutations affect only a single copy of the genes in each parent, but the children had them in two copies, one from each parent.

Casanova’s team believed that one mutated gene in particular, called NLRP1, stood out as a the most likely culprit to because it is known to be important for the immune system. It produces a component of the ‘inflammasome,’ a protein complex that helps the body detect and shake off pathogens.

The scientists suspected they were on the right track when they found that skin cells from one of the boys secreted excess IL-1b, a molecule produced by the inflammasome. And when they treated the cells with a drug that activates the inflammasome, it didn’t further boost IL-1b levels as it did for control cells. They also analyzed blood samples from the boys and found that both have elevated levels of IL-18, another inflammatory molecule secreted by the inflammasome. All of these pieces of evidence indicate that the boys’ NLRP1 mutation leads to hyperactivation of the inflammasome.

It’s unclear exactly why the boys developed the warts, however, because the researchers did not detect the typical wart-causing strains of HPV in either child. It’s possible that the boys were once infected with the virus and that the infection hyperactivated the inflammasome, making it eradicate the virus while inducing other problems. For example, a hyperactive inflammasome could induce skin cells lining the throat to grow excessively, making warts form in the process. Another possibility is that the boys were infected with very small numbers of viruses that remained undetected in the biopsies.

 

Dr. Jean-Laurent Casanova

Jean-Laurent Casanova
Professor
Investigator, Howard Hughes Medical Institute
Senior Attending Physician
St. Giles Laboratory of Human Genetics of Infectious Diseases


Related publication

Proceedings of the National Academy of Sciences
Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis
Scott B. Drutman, Filomeen Haerynck, Franklin L. Zhong, David Hum, Nicholas J. Hernandez, Serkan Belkaya, Franck Rapaport, Sarah Jill de Jong, David Creytens, Simon J. Tavernier, Katrien Bonte, Sofie De Schepper, Jutte van der Werff ten Bosch, Lazaro Lorenzo-Diaz, Andy Wullaert, Xavier Bossuyt, Gérard Orth, Vincent R. Bonagura, Vivien Béziat, Laurent Abel, Emmanuelle Jouanguy, Bruno Reversade, and Jean-Laurent Casanova


Sign up for our monthly newsletter



Media contact

Katherine Fenz
Media Relations Manager


More news

Browse our recent stories.